Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
13 hedge funds and large institutions have $13.9M invested in Allergan Inc in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 12 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
38% less capital invested
Capital invested by funds: $22.3M → $13.9M (-$8.43M)
43% less funds holding
Funds holding: 23 → 13 (-10)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Frontier Investment Management
Dallas,
Texas
|
+$7.57M |
| 2 |
MCM
Mengis Capital Management
Portland,
Oregon
|
+$1.44M |
| 3 |
GIM
Grassi Investment Management
Santa Clara,
California
|
+$569K |
| 4 |
HHAA
Henry H. Armstrong Associates
Pittsburgh,
Pennsylvania
|
+$254K |
| 5 |
BC
Bartlett & Co
Cincinnati,
Ohio
|
+$7.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
-$9.16M |
| 2 |
AWM
Altavista Wealth Management
Asheville,
North Carolina
|
-$3.18M |
| 3 |
ODCM
Old Dominion Capital Management
Charlottesville,
Virginia
|
-$969K |
| 4 |
AGA
Accuvest Global Advisors
Provo,
Utah
|
-$584K |
| 5 |
LCM
Liberty Capital Management
Birmingham,
Michigan
|
-$571K |
AGN Hedge Fund Activity: Q2 2016 in Review
13 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2016, worth a combined $13.9M — down 38% from $22.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of AGN and 3 opened new positions — a net loss of 9 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Frontier Investment Management, opening a new position worth an estimated $7.57M. The largest seller was Sand Grove Capital Management, exiting entirely with an estimated $9.16M sold.
- 13 institutional investors held Allergan Inc (AGN) as of Q2 2016, down from 23 in Q1 2016.
- Funds reported $13.9M of Allergan Inc stock for Q2 2016, down 38% quarter-over-quarter.
- 3 funds opened new Allergan Inc positions in Q2 2016 and 12 closed out, a net change of -9 holders.
- The largest Allergan Inc buyer in Q2 2016 was Frontier Investment Management, an estimated $7.57M added.
- The largest Allergan Inc seller in Q2 2016 was Sand Grove Capital Management, an estimated $9.16M sold.
Based on aggregated 13F filings for Q2 2016.